The present invention relates to immunosuppressant, process for their production, their uses and pharmaceutical compositions containing them. The invention provides a novel class of compounds useful in the treatment or prevention of diseases or disorders mediated by lymphocyte interactions, particularly diseases associated with EDG receptor mediated signal transduction.

 
Web www.patentalert.com

< Emulsion polymerization process utilizing ethylenically unsaturated amine salts of sulfonic, phosphoric and carboxylic acids

< Electromechanical display panel incorporating a porous movable film

> Self-assembled sub-nanolayers as interfacial adhesion enhancers and diffusion barriers

> Particulate carbonates and their preparation and use in breathable film
~ 00269